Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
AZTR is expected to report earnings to fall 32.26% to -20 cents per share on November 18
Q3'25
Est.
$-0.21
Q4'24
Beat
by $0.20
The last earnings report on February 24 showed earnings per share of -31 cents, beating the estimate of -50 cents. With 335.43K shares outstanding, the current market capitalization sits at 3.44M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AZTR showed earnings on February 24, 2025. You can read more about the earnings report here.